We are live on ! Find out more
MMYT icon

MakeMyTrip

100 hedge funds and large institutions have $1.14B invested in MakeMyTrip in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 42 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

0.2% less ownership

Funds ownership: 65.37%65.16% (-0.2%)

4% less capital invested

Capital invested by funds: $1.18B → $1.14B (-$42.4M)

6% less funds holding

Funds holding: 106100 (-6)

14% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 42

31% less call options, than puts

Call options by funds: $527K | Put options by funds: $768K

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

Holders
100
Holders Change
-6
Holders Change %
-5.66%
% of All Funds
1.58%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
10
Increased
36
Reduced
42
Closed
16
Calls
$527K
Puts
$768K
Net Calls
-$241K
Net Calls Change
-$4.07M
Name Holding Trade Value Shares
Change
Change in
Stake
CFM
26
Coronation Fund Managers
South Africa
$8.59M -$241K -9,351 -3%
RC
27
RBF Capital
California
$8.49M +$129K +5,000 +2%
Bank of America
28
Bank of America
North Carolina
$6.23M +$2.01M +78,114 +51%
Citadel Advisors
29
Citadel Advisors
Florida
$6.01M +$1.41M +54,803 +32%
Allianz Asset Management
30
Allianz Asset Management
Germany
$5.15M +$89K +3,454 +2%
PCM
31
Penserra Capital Management
California
$4.71M -$1.04M -40,397 -19%
RGI
32
River Global Investors
United Kingdom
$4.67M -$622K -24,130 -12%
Grantham, Mayo, Van Otterloo & Co (GMO)
33
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$4.61M -$1.08M -42,000 -20%
CIS
34
Capital International Sarl
California
$2.97M +$707K +27,419 +33%
First Trust Advisors
35
First Trust Advisors
Illinois
$2.8M -$224K -8,695 -8%
HighTower Advisors
36
HighTower Advisors
Illinois
$2.61M +$16.8K +651 +0.7%
Neuberger Berman Group
37
Neuberger Berman Group
New York
$2.46M +$208K +8,060 +10%
BlackRock
38
BlackRock
New York
$2.23M -$93.2K -3,616 -4%
Citigroup
39
Citigroup
New York
$2.13M -$156K -6,068 -7%
Fisher Asset Management
40
Fisher Asset Management
Washington
$1.96M -$5.03K -195 -0.3%
UBS Group
41
UBS Group
Switzerland
$1.93M +$1.62M +62,887 +709%
SRAM
42
Spouting Rock Asset Management
Pennsylvania
$1.84M
State Street
43
State Street
Massachusetts
$1.75M +$376K +14,577 +29%
BCAM
44
Boston Common Asset Management
Massachusetts
$1.69M +$113K +4,385 +8%
EDRH
45
Edmond de Rothschild Holding
Switzerland
$1.68M +$96.4K +3,740 +6%
Goldman Sachs
46
Goldman Sachs
New York
$1.52M +$316K +12,243 +28%
Geode Capital Management
47
Geode Capital Management
Massachusetts
$1.51M +$7.32K +284 +0.5%
Nomura Holdings
48
Nomura Holdings
Japan
$1.23M
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
$1.1M +$1.06M +41,128 New
HSBC Holdings
50
HSBC Holdings
United Kingdom
$1.03M -$2.18M -84,619 -69%

MMYT Hedge Fund Activity: Q1 2022 in Review

100 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in MakeMyTrip (MMYT) for Q1 2022, worth a combined $1.14B — down 3.6% from $1.18B a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of MMYT and 10 opened new positions — a net loss of 6 holders — while 42 trimmed existing stakes and 36 added.

The largest buyer was Brown Advisory, adding an estimated $16.3M. The largest seller was Fidelity Investments, cutting an estimated $19.8M.

  • 100 institutional investors held MakeMyTrip (MMYT) as of Q1 2022, down from 106 in Q4 2021.
  • Funds reported $1.14B of MakeMyTrip stock for Q1 2022, down 3.6% quarter-over-quarter.
  • 10 funds opened new MakeMyTrip positions in Q1 2022 and 16 closed out, a net change of -6 holders.
  • The largest MakeMyTrip buyer in Q1 2022 was Brown Advisory, an estimated $16.3M added.
  • The largest MakeMyTrip seller in Q1 2022 was Fidelity Investments, an estimated $19.8M sold.

Based on aggregated 13F filings for Q1 2022.